Table:
begin	end	state
1	11	cytoplasmic
12	29	transmembrane
30	34	non-cytoplasmic
35	54	transmembrane
55	90	cytoplasmic
91	113	transmembrane
114	119	non-cytoplasmic
120	141	transmembrane
142	161	cytoplasmic
162	185	transmembrane
186	191	non-cytoplasmic
192	211	transmembrane
212	222	cytoplasmic
223	242	transmembrane
243	257	non-cytoplasmic
258	278	transmembrane
279	284	cytoplasmic
285	303	transmembrane
304	325	non-cytoplasmic
326	347	transmembrane
348	366	cytoplasmic
367	387	transmembrane
388	487	non-cytoplasmic
488	507	transmembrane
508	532	cytoplasmic
533	552	transmembrane
553	564	non-cytoplasmic
565	589	transmembrane
590	595	cytoplasmic
596	616	transmembrane
617	664	non-cytoplasmic
665	687	transmembrane
688	716	cytoplasmic


Input:
>18378 FitnessBrowser__Keio:18378
MDTKKIFKHIPWVILGIIGAFCLAVVALRRGEHISALWIVVASVSVYLVAYRYYSLYIAQ
KVMKLDPTRATPAVINNDGLNYVPTNRYVLFGHHFAAIAGAGPLVGPVLAAQMGYLPGTL
WLLAGVVLAGAVQDFMVLFISSRRNGASLGEMIKEEMGPVPGTIALFGCFLIMIIILAVL
ALIVVKALAESPWGVFTVCSTVPIALFMGIYMRFIRPGRVGEVSVIGIVLLVASIYFGGV
IAHDPYWGPALTFKDTTITFALIGYAFVSALLPVWLILAPRDYLATFLKIGVIVGLALGI
VVLNPELKMPAMTQYIDGTGPLWKGALFPFLFITIACGAVSGFHALISSGTTPKLLANET
DARFIGYGAMLMESFVAIMALVAASIIEPGLYFAMNTPPAGLGITMPNLHEMGGENAPII
MAQLKDVTAHAAATVSSWGFVISPEQILQTAKDIGEPSVLNRAGGAPTLAVGIAHVFHKV
LPMADMGFWYHFGILFEALFILTALDAGTRSGRFMLQDLLGNFIPFLKKTDSLVAGIIGT
AGCVGLWGYLLYQGVVDPLGGVKSLWPLFGISNQMLAAVALVLGTVVLIKMKRTQYIWVT
VVPAVWLLICTTWALGLKLFSTNPQMEGFFYMASQYKEKIANGTDLTAQQIANMNHIVVN
NYTNAGLSILFLIVVYSIIFYGFKTWLAVRNSDKRTDKETPYVPIPEGGVKISSHH

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server